Trade Summary

2 days ago, Preblick Ryan, serving as Chief Financial Officer at Indivior Pharmaceuticals, Inc. (INDV), sold 36,000 shares at $37.70 per share, for a total transaction value of $1,357,200.00. Following this transaction, Preblick Ryan now holds 284,751 shares of INDV.

This sale represents a 11.22% decrease in Preblick Ryan's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 8, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 10, 2026 at 6:04 AM ET, 2 days after the trade was made.

Indivior Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.